Cancer Research UK Centre
UCL becomes home to London's first Cancer Research UK Centre in October 2009
The UCL (University College London) Cancer Research UK Centre will foster world class research into the causes of cancers and why they develop, and use this knowledge to develop new drugs and therapies.
In particular the UCL Centre will focus on the biology and treatment of blood cancers, sarcomas, brain cancer, ovarian cancer, head and neck cancer and lung cancer.
Many of these cancers –particularly lung and brain- are hard to treat successfully and have poor long term survival rates compared to other common cancers.
Collaboration is the key to the success of the Centre which will focus on new treatments such as gene therapy, health behaviours and drug discovery.
Professor David Linch, director of the new UCL Cancer Research UK Centre, said: "By joining the network of Cancer Research UK Centres across the UK we will be able to build on our world class research bringing benefits to patients, doctors and scientists.
"This new centre will strengthen the work we already do in taking new treatments straight from the laboratory to the clinic, bringing real benefits to people with cancer. Our vision is to supply high quality care to all patients by creating research platforms that enable the development of new and innovative therapies."
The centre aims to be a world leader in developing treatments tailored to individual cancers based on the biology of the disease and how that varies between patients. It brings together researchers and clinicians from UCL and its four partner hospital trusts, known as UCL Partners: University College London Hospital NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Trust, the Royal Free Hampstead NHS Trust, and Moorfields Eye Hospital NHS Foundation Trust, as well as the London School of Pharmacy and Cancer Research UK.
The Centre will make small grants available to encourage researchers from different fields, such as mathematicians and physicists, to bring their expertise into the search for new treatments.
UCL Cancer Institute
Paul O'Gorman Building
University College London
72 Huntley Street